Testing a new panel to detect COVID-19 and other coronaviruses
Part of Infections, Lungs & breathing clinical trials.
This trial uses leftover nasal swab samples to test a new panel that can detect COVID-19 and other coronaviruses. It helps see if the panel works well for diagnosing these infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have had a nasal swab test ordered by a doctor for a respiratory infection.
- The leftover sample must be kept at room temperature for 4 hours or less, or in a fridge for 72 hours or less.
- There must be at least 1.7 mL of leftover sample after standard testing.
- The transport medium (the liquid in the sample tube) must be known and can be either VTM or UTM.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new, easy-to-use COVID-19 test called the Metrix COVID-19 Test. If you have a fever or other cold or flu-like symptoms today, you may help confirm if this test works well.
This study tracks how respiratory viruses spread in the community and within households. It involves testing and collecting samples from people who are sick or healthy, to help better understand and prevent outbreaks.
This trial evaluates a new test that can detect flu A/B, RSV, and COVID-19 from a single nose swab. It is for people who are currently sick with respiratory symptoms and are either hospitalized, in the ER, visiting a clinic, or living in a long-term care facility.
This trial is testing a new at-home test for respiratory infections like the flu and COVID-19. The test is done by you or a caregiver using a nose swab. It may help you get quick and accurate results without going to a clinic.
This study tests “new technologies” to identify what virus is causing a respiratory illness, using samples taken from inside your nose. It may help doctors get faster, more accurate answers about the cause of your symptoms.
This study collects samples from people who currently have, recently had, or may have been exposed to common respiratory viruses. The goal is to use these samples to develop and test future countermeasures (like treatments) against COVID-19 and other viruses.
Hear when a new Coronavirus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.